NEW YORK (GenomeWeb) – A team of Swedish researchers has received SEK 30 million ($3.3 million) to develop a new nanotechnology platform for detecting blood-borne markers in lung and breast cancer.

The Royal Institute of Technology (KTH) is leading the new project which is set to commence in January 2017. Researchers from Karolinska Institutet, SciLifeLab, and Acreo Swedish ICT, an electronics research institute based in Stockholm, are also taking part in the effort, which is being primarily funded via the Erling-Persson Family Foundation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.